Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome.
van Hoek
B
B
Liver Transplantation Unit, Mayo Clinic, Rochester, Minnesota 55905.
Wiesner
R H
RH
Ludwig
J
J
Paya
C
C
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001652:Bile Ducts / Q000473:pathology; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents; D016031:Liver Transplantation / Q000473:pathology*; D012307:Risk Factors; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D001379:Azathioprine; D016559:Tacrolimus